Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Hereditary Cancer Testing market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Hereditary Cancer Testing market. Detailed analysis of key players, along with key growth strategies adopted by Hereditary Cancer Testing industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Strand Life Sciences
Laboratory Corporation of America
Myriad Genetics
Biocartis
Myogenes
Pathway Genomics
Quest Diagnostics
Invitae Corporation
By Type:
Biopsy
Imaging
Others
By End-User:
Hospital
Clinics
Diagnostic Centers
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Hereditary Cancer Testing Market
-
1.3 Market Segment by Type
-
1.3.1 China Hereditary Cancer Testing Market Size and Growth Rate of Biopsy from 2016 to 2027
-
1.3.2 China Hereditary Cancer Testing Market Size and Growth Rate of Imaging from 2016 to 2027
-
1.3.3 China Hereditary Cancer Testing Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Hereditary Cancer Testing Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.2 China Hereditary Cancer Testing Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 China Hereditary Cancer Testing Market Size and Growth Rate of Diagnostic Centers from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Hereditary Cancer Testing Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Hereditary Cancer Testing by Major Types
-
3.4.1 Market Size and Growth Rate of Biopsy
-
3.4.2 Market Size and Growth Rate of Imaging
-
3.4.3 Market Size and Growth Rate of Others
4 Segmentation of Hereditary Cancer Testing Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Hereditary Cancer Testing by Major End-Users
-
4.4.1 Market Size and Growth Rate of Hereditary Cancer Testing in Hospital
-
4.4.2 Market Size and Growth Rate of Hereditary Cancer Testing in Clinics
-
4.4.3 Market Size and Growth Rate of Hereditary Cancer Testing in Diagnostic Centers
5 Market Analysis by Regions
-
5.1 China Hereditary Cancer Testing Production Analysis by Regions
-
5.2 China Hereditary Cancer Testing Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Hereditary Cancer Testing Landscape Analysis
-
6.1 North China Hereditary Cancer Testing Landscape Analysis by Major Types
-
6.2 North China Hereditary Cancer Testing Landscape Analysis by Major End-Users
7 Central China Hereditary Cancer Testing Landscape Analysis
-
7.1 Central China Hereditary Cancer Testing Landscape Analysis by Major Types
-
7.2 Central China Hereditary Cancer Testing Landscape Analysis by Major End-Users
8 South China Hereditary Cancer Testing Landscape Analysis
-
8.1 South China Hereditary Cancer Testing Landscape Analysis by Major Types
-
8.2 South China Hereditary Cancer Testing Landscape Analysis by Major End-Users
9 East China Hereditary Cancer Testing Landscape Analysis
-
9.1 East China Hereditary Cancer Testing Landscape Analysis by Major Types
-
9.2 East China Hereditary Cancer Testing Landscape Analysis by Major End-Users
10 Northeast China Hereditary Cancer Testing Landscape Analysis
-
10.1 Northeast China Hereditary Cancer Testing Landscape Analysis by Major Types
-
10.2 Northeast China Hereditary Cancer Testing Landscape Analysis by Major End-Users
11 Southwest China Hereditary Cancer Testing Landscape Analysis
-
11.1 Southwest China Hereditary Cancer Testing Landscape Analysis by Major Types
-
11.2 Southwest China Hereditary Cancer Testing Landscape Analysis by Major End-Users
12 Northwest China Hereditary Cancer Testing Landscape Analysis
-
12.1 Northwest China Hereditary Cancer Testing Landscape Analysis by Major Types
-
12.2 Northwest China Hereditary Cancer Testing Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Strand Life Sciences
-
13.1.1 Strand Life Sciences Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Laboratory Corporation of America
-
13.2.1 Laboratory Corporation of America Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Myriad Genetics
-
13.3.1 Myriad Genetics Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Biocartis
-
13.4.1 Biocartis Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Myogenes
-
13.5.1 Myogenes Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Pathway Genomics
-
13.6.1 Pathway Genomics Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Quest Diagnostics
-
13.7.1 Quest Diagnostics Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Invitae Corporation
-
13.8.1 Invitae Corporation Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Hereditary Cancer Testing Market Size and Growth Rate of Biopsy from 2016 to 2027
-
Figure China Hereditary Cancer Testing Market Size and Growth Rate of Imaging from 2016 to 2027
-
Figure China Hereditary Cancer Testing Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Hereditary Cancer Testing Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Hereditary Cancer Testing Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure China Hereditary Cancer Testing Market Size and Growth Rate of Diagnostic Centers from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Hereditary Cancer Testing Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Hereditary Cancer Testing Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Hereditary Cancer Testing
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Hereditary Cancer Testing by Different Types from 2016 to 2027
-
Table Consumption Share of Hereditary Cancer Testing by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Biopsy
-
Figure Market Size and Growth Rate of Imaging
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Hereditary Cancer Testing by Different End-Users from 2016 to 2027
-
Table Consumption Share of Hereditary Cancer Testing by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Diagnostic Centers
-
Table China Hereditary Cancer Testing Production by Regions
-
Table China Hereditary Cancer Testing Production Share by Regions
-
Figure China Hereditary Cancer Testing Production Share by Regions in 2016
-
Figure China Hereditary Cancer Testing Production Share by Regions in 2021
-
Figure China Hereditary Cancer Testing Production Share by Regions in 2027
-
Table China Hereditary Cancer Testing Consumption by Regions
-
Table China Hereditary Cancer Testing Consumption Share by Regions
-
Figure China Hereditary Cancer Testing Consumption Share by Regions in 2016
-
Figure China Hereditary Cancer Testing Consumption Share by Regions in 2021
-
Figure China Hereditary Cancer Testing Consumption Share by Regions in 2027
-
Table North China Hereditary Cancer Testing Consumption by Types from 2016 to 2027
-
Table North China Hereditary Cancer Testing Consumption Share by Types from 2016 to 2027
-
Figure North China Hereditary Cancer Testing Consumption Share by Types in 2016
-
Figure North China Hereditary Cancer Testing Consumption Share by Types in 2021
-
Figure North China Hereditary Cancer Testing Consumption Share by Types in 2027
-
Table North China Hereditary Cancer Testing Consumption by End-Users from 2016 to 2027
-
Table North China Hereditary Cancer Testing Consumption Share by End-Users from 2016 to 2027
-
Figure North China Hereditary Cancer Testing Consumption Share by End-Users in 2016
-
Figure North China Hereditary Cancer Testing Consumption Share by End-Users in 2021
-
Figure North China Hereditary Cancer Testing Consumption Share by End-Users in 2027
-
Table Central China Hereditary Cancer Testing Consumption by Types from 2016 to 2027
-
Table Central China Hereditary Cancer Testing Consumption Share by Types from 2016 to 2027
-
Figure Central China Hereditary Cancer Testing Consumption Share by Types in 2016
-
Figure Central China Hereditary Cancer Testing Consumption Share by Types in 2021
-
Figure Central China Hereditary Cancer Testing Consumption Share by Types in 2027
-
Table Central China Hereditary Cancer Testing Consumption by End-Users from 2016 to 2027
-
Table Central China Hereditary Cancer Testing Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Hereditary Cancer Testing Consumption Share by End-Users in 2016
-
Figure Central China Hereditary Cancer Testing Consumption Share by End-Users in 2021
-
Figure Central China Hereditary Cancer Testing Consumption Share by End-Users in 2027
-
Table South China Hereditary Cancer Testing Consumption by Types from 2016 to 2027
-
Table South China Hereditary Cancer Testing Consumption Share by Types from 2016 to 2027
-
Figure South China Hereditary Cancer Testing Consumption Share by Types in 2016
-
Figure South China Hereditary Cancer Testing Consumption Share by Types in 2021
-
Figure South China Hereditary Cancer Testing Consumption Share by Types in 2027
-
Table South China Hereditary Cancer Testing Consumption by End-Users from 2016 to 2027
-
Table South China Hereditary Cancer Testing Consumption Share by End-Users from 2016 to 2027
-
Figure South China Hereditary Cancer Testing Consumption Share by End-Users in 2016
-
Figure South China Hereditary Cancer Testing Consumption Share by End-Users in 2021
-
Figure South China Hereditary Cancer Testing Consumption Share by End-Users in 2027
-
Table East China Hereditary Cancer Testing Consumption by Types from 2016 to 2027
-
Table East China Hereditary Cancer Testing Consumption Share by Types from 2016 to 2027
-
Figure East China Hereditary Cancer Testing Consumption Share by Types in 2016
-
Figure East China Hereditary Cancer Testing Consumption Share by Types in 2021
-
Figure East China Hereditary Cancer Testing Consumption Share by Types in 2027
-
Table East China Hereditary Cancer Testing Consumption by End-Users from 2016 to 2027
-
Table East China Hereditary Cancer Testing Consumption Share by End-Users from 2016 to 2027
-
Figure East China Hereditary Cancer Testing Consumption Share by End-Users in 2016
-
Figure East China Hereditary Cancer Testing Consumption Share by End-Users in 2021
-
Figure East China Hereditary Cancer Testing Consumption Share by End-Users in 2027
-
Table Northeast China Hereditary Cancer Testing Consumption by Types from 2016 to 2027
-
Table Northeast China Hereditary Cancer Testing Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Hereditary Cancer Testing Consumption Share by Types in 2016
-
Figure Northeast China Hereditary Cancer Testing Consumption Share by Types in 2021
-
Figure Northeast China Hereditary Cancer Testing Consumption Share by Types in 2027
-
Table Northeast China Hereditary Cancer Testing Consumption by End-Users from 2016 to 2027
-
Table Northeast China Hereditary Cancer Testing Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Hereditary Cancer Testing Consumption Share by End-Users in 2016
-
Figure Northeast China Hereditary Cancer Testing Consumption Share by End-Users in 2021
-
Figure Northeast China Hereditary Cancer Testing Consumption Share by End-Users in 2027
-
Table Southwest China Hereditary Cancer Testing Consumption by Types from 2016 to 2027
-
Table Southwest China Hereditary Cancer Testing Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Hereditary Cancer Testing Consumption Share by Types in 2016
-
Figure Southwest China Hereditary Cancer Testing Consumption Share by Types in 2021
-
Figure Southwest China Hereditary Cancer Testing Consumption Share by Types in 2027
-
Table Southwest China Hereditary Cancer Testing Consumption by End-Users from 2016 to 2027
-
Table Southwest China Hereditary Cancer Testing Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Hereditary Cancer Testing Consumption Share by End-Users in 2016
-
Figure Southwest China Hereditary Cancer Testing Consumption Share by End-Users in 2021
-
Figure Southwest China Hereditary Cancer Testing Consumption Share by End-Users in 2027
-
Table Northwest China Hereditary Cancer Testing Consumption by Types from 2016 to 2027
-
Table Northwest China Hereditary Cancer Testing Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Hereditary Cancer Testing Consumption Share by Types in 2016
-
Figure Northwest China Hereditary Cancer Testing Consumption Share by Types in 2021
-
Figure Northwest China Hereditary Cancer Testing Consumption Share by Types in 2027
-
Table Northwest China Hereditary Cancer Testing Consumption by End-Users from 2016 to 2027
-
Table Northwest China Hereditary Cancer Testing Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Hereditary Cancer Testing Consumption Share by End-Users in 2016
-
Figure Northwest China Hereditary Cancer Testing Consumption Share by End-Users in 2021
-
Figure Northwest China Hereditary Cancer Testing Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Strand Life Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Strand Life Sciences
-
Figure Sales and Growth Rate Analysis of Strand Life Sciences
-
Figure Revenue and Market Share Analysis of Strand Life Sciences
-
Table Product and Service Introduction of Strand Life Sciences
-
Table Company Profile and Development Status of Laboratory Corporation of America
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Laboratory Corporation of America
-
Figure Sales and Growth Rate Analysis of Laboratory Corporation of America
-
Figure Revenue and Market Share Analysis of Laboratory Corporation of America
-
Table Product and Service Introduction of Laboratory Corporation of America
-
Table Company Profile and Development Status of Myriad Genetics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myriad Genetics
-
Figure Sales and Growth Rate Analysis of Myriad Genetics
-
Figure Revenue and Market Share Analysis of Myriad Genetics
-
Table Product and Service Introduction of Myriad Genetics
-
Table Company Profile and Development Status of Biocartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocartis
-
Figure Sales and Growth Rate Analysis of Biocartis
-
Figure Revenue and Market Share Analysis of Biocartis
-
Table Product and Service Introduction of Biocartis
-
Table Company Profile and Development Status of Myogenes
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Myogenes
-
Figure Sales and Growth Rate Analysis of Myogenes
-
Figure Revenue and Market Share Analysis of Myogenes
-
Table Product and Service Introduction of Myogenes
-
Table Company Profile and Development Status of Pathway Genomics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pathway Genomics
-
Figure Sales and Growth Rate Analysis of Pathway Genomics
-
Figure Revenue and Market Share Analysis of Pathway Genomics
-
Table Product and Service Introduction of Pathway Genomics
-
Table Company Profile and Development Status of Quest Diagnostics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quest Diagnostics
-
Figure Sales and Growth Rate Analysis of Quest Diagnostics
-
Figure Revenue and Market Share Analysis of Quest Diagnostics
-
Table Product and Service Introduction of Quest Diagnostics
-
Table Company Profile and Development Status of Invitae Corporation
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Invitae Corporation
-
Figure Sales and Growth Rate Analysis of Invitae Corporation
-
Figure Revenue and Market Share Analysis of Invitae Corporation
-
Table Product and Service Introduction of Invitae Corporation
-
